Lewis on Oncology
Mark A. Lewis, MD, is director of gastrointestinal oncology at Intermountain Healthcare in Utah. Specializing in cancers of the gastrointestinal tract and accessory organs, his interests focus on hereditary cancer syndromes and young-onset cancers, shared decision-making, and patient-physician communication.
+ Add to Email Alerts
+ Add to Email Alerts
- ASCO 2024 ASCO 2024: 'The Oncologist Without the Pathologist Is Blind'
- Word Choice and Royals: The Need To Be Clear and Precise
- NordICC Controversies: Practice Differences in Europe and the US
- Healthcare Violence: Docs Bear Brunt of Business Pressures
- MOC: An 'Insult to Oncologists' Engaged in Patient Care
- De-escalating Cancer Tx Should Be Celebrated, Not Criticized
- High Hopes, Dashed Dreams: Progress in GI Cancers at ASCO
- 2023 ASCO GI Symposium: New, Measured Optimism
- Best CRC Treatment De-intensification: Better Screening
- Three Trials From ASCO GI Renew Hope
- A Dying Patient's Request: Return My Trial Results
- OpenNotes: Advice From an Oncologist Who Survived Cancer
- ASCO 2021 ASCO 2021's Best Trials Proved We Can Do More With Less
- COVID-19 and Cancer Treatment: Where Do We Currently Stand?
- Lifestyle Alone Cannot Shield Us From Cancer
- Highlights From ASCO GI: Data That Will 'Advance Care'
- Positive Takeaways From This Annus Horribilis
- A Seismic Shift in Colorectal Cancer Screening
- Unmasking Mask Misinformation and Myths
- The Oncologist's Role With Savvy Patients